| mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.0039 |
0.9 |
| mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.9 |
| mRNA |
Docetaxel |
CTRPv2 |
pan-cancer |
AAC |
0.0051 |
0.9 |
| mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0037 |
0.9 |
| mRNA |
ML006 |
CTRPv2 |
pan-cancer |
AAC |
0.0036 |
0.9 |
| mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.0036 |
0.9 |
| mRNA |
WAY-362450 |
CTRPv2 |
pan-cancer |
AAC |
-0.0035 |
0.9 |
| mRNA |
PHA-665752 |
GDSC1000 |
pan-cancer |
AAC |
-0.005 |
0.9 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0033 |
0.9 |
| mRNA |
Pazopanib |
GDSC1000 |
pan-cancer |
AAC |
-0.003 |
0.9 |